SBK Financial’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
SBK Financial's AZN Position: Q2 2026 in Review
SBK Financial sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 78 shares — an estimated $15.4K sold.
SBK Financial first reported a position in AZN in Q1 2026 and held it in 1 quarter. The position peaked at $15.4K in Q1 2026. 1,515 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- SBK Financial reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
- SBK Financial sold 78 AstraZeneca shares in Q2 2026, an estimated $15.4K.
- SBK Financial first reported a position in AstraZeneca in Q1 2026 and held it in 1 quarter.
- SBK Financial's AstraZeneca position peaked at $15.4K in Q1 2026.
- 1,515 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on SBK Financial's 13F filing for Q2 2026, filed 2 Nov 2026.